Accelagen Pty Ltd

The good news keeps coming at Accelagen Pty Ltd with Elle Guest joining the executive leadership team as our new Executive Director of Operations. With a PhD in #Pharmacokinetics and over 14 years of experience in #ClinicalOperations and APAC expansion, Eleanor brings a strategic, people-first approach to leadership. 💬 “Australian biotech is advancing at an incredible pace, with world-class research, innovative companies, and strong industry partnerships driving the sector forward. It’s an exciting time to be in clinical research, and at Accelagen—not just in terms of operational efficiency, but in how we drive innovation to help shape the future.” Join us in welcoming Eleanor to our growing team! 🎉 https://lnkd.in/g8-JRZ7K #ClinicalResearch #CRO #Biotech #Leadership #Accelagen #ClinicalTrials#Operations

We're #hiring a new Payroll Manager in Hawthorn, Victoria. Apply today or share this post with your network.

We're Hiring! Join our growing team at Accelagen and explore exciting career opportunities. If you're looking to grow professionally within a company that values a supportive, positive and inclusive culture, we’d love to hear from you! Apply today and take the next step in making a meaningful impact as we accelerate the future of human health and wellness. #WeareRecruiting #AccelagenCareerOpportunities #AccelagenCareers #ApplyNow

Meet with us in Texas! Accelagen Pty Ltd looks forward to showing how the #AustralianAdvantage can help propel your #ClinicalDevelopment program and make your investment dollars go further! We are excited to attend BioLife Summits Texas BioLife conference in Dallas on February 27th. Reach out to Trent Wadford (Senior Director of Business Development, United States) to discuss the end-to-end services we offer across Strategic Consultation, #ClinicalTrials, #RegulatoryAffairs, #Biometrics, #MedicalSafety, and #Pharmacovigilance!

This year’s recent 43rd annual J.P. Morgan #HealthcareConference, held in San Francisco, provided a much-needed boost of cautious optimism, marking a turning point as the #lifescience industry looks to 2025 and beyond. Accelagen Pty Ltd’s leadership, CEO Greg Plunkett and Chief Growth & Commercial Officer Mathew Palmer, attended the conference and shared valuable insights on the current landscape and the company’s outlook for the year ahead in our most recent blog post. To read it now, click here: https://lnkd.in/gfjnkYBA

We are recruiting! Are you passionate about discovering top-tier talent in the Clinical Research industry? Join us at Accelagen as a Talent Acquisition Specialist! As we continue to expand and meet the evolving demands of the clinical research landscape, we're looking for a recruitment expert with experience in the CRO market. In this critical role, you'll identify and engage exceptional talent, ensuring we have the right people in the right positions to drive our success and support our growth. If you're ready to make an impact in a dynamic, fast-paced environment, we’d love to hear from you! Please apply via the link below or submit your resume and cover letter outlining your experience and qualifications to careers@accelagen.com.au. https://lnkd.in/gKHdP4QN #WeareHiring #AccelagenRecruitment #TalentAquisitionSpecialist #Applynow

The team at Accelagen Pty Ltd is thrilled to welcome Mathew Palmer as our new Chief Growth & Commercial Officer (CGCO). With an exceptional track record spanning nearly 30 years in the #LifeSciences industry, Mathew’s experience and leadership will be invaluable as we continue to expand and enhance our services. In this post, we introduce Mathew, highlight his professional journey, and discuss what his appointment means for the future of Accelagen. To read more about Mathew and his new role at Accelagen, click here: https://lnkd.in/g6Fe7W7N

The team from Accelagen Pty Ltd is attending the #BiotechShowcase in association with the J.P. Morgan #HealthConference in San Francisco. Our CEO Greg Plunkett, our Chief Growth & Commercial Officer Mathew Palmer, and our new Senior Director of United States Business Development Trent Wadford are looking forward to connecting with friends, colleagues and other #healthcare professionals, #investors, and #innovators within the #LifeScience sector and showcase our capabilities in #DrugDevelopment services and share insights into the strategic advantages of leveraging strong Australian partners for #ClinicalTrials. Click here to schedule a time to meet with us using the PartneringONE Portal: https://lnkd.in/gyweXiB6

In a pioneering collaboration, Accelagen Pty Ltd is joining forces with Griffith University to support a world-first #PhaseI #ClinicalTrial that could revolutionise the treatment of #SpinalCordInjuries (SCI). This groundbreaking study, which focuses on a novel #CellBasedTherapy, aims to restore lost functions in patients with severe #SpinalCordDamage and offers hope for those affected by one of the most debilitating conditions worldwide. To read more about this story, click here: https://lnkd.in/gxSt89Cu

Next month, Accelagen Pty Ltd will be attending the highly anticipated #BiotechShowcase in association with the J.P. Morgan #HealthConference in San Francisco, marking another pivotal moment in the #biotech industry’s calendar. As one of the most important global gatherings for #healthcare professionals, industry #investors, and #innovators, the #JPMorganHealthConference serves as a hub for discussions on the latest trends, breakthroughs, and future opportunities within the #LifeScience sector. For Accelagen, this is an opportunity to extend our connections, showcase our capabilities in #DrugDevelopment services and share insights into the strategic advantages of leveraging strong Australian partners for #ClinicalTrials. To read more and schedule a meeting with us in San Francisco, click here: https://lnkd.in/gF4VMTcr